|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$35,000
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-07
|
$27,646,062
|
$3,870,449
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-07
|
$5,725,544
|
$801,576
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-16
|
$5,084,061
|
$50,841
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$220,828
|
Fojo, Antonio
|
CCR (NCI)
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-21
|
$3,525,298
|
$387,783
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$753,141
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-40
|
$2,527,733
|
$75,832
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
Radiologial Physics Center
|
5U10CA010953-41
|
$2,487,286
|
$74,619
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,324,038
|
$116,202
|
Wayne, Alan
|
CCR (NCI)
|
|
SPORE in Lymphoma
|
5P50CA126752-03
|
$2,266,618
|
$679,985
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-08
|
$2,126,089
|
$297,652
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mixed Hematopoietic Chimerism After Stem Cell Allografts
|
2P01CA078902-11
|
$1,991,605
|
$59,748
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
GVL without GVHD across HLA barriers: Translational Studies
|
5P01CA111519-04
|
$1,902,623
|
$633,573
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-15
|
$1,893,674
|
$189,367
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
In Vivo Cellular and Molecualr Imaging Center@Stanford
|
5P50CA114747-05
|
$1,830,518
|
$109,831
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Quality Assurance Review Center
|
5U10CA029511-30
|
$1,737,151
|
$52,115
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Stanford University Cancer Center
|
5P30CA124435-03
|
$1,611,344
|
$16,113
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,571,033
|
$235,655
|
Pastan, Ira
|
CCR (NCI)
|
|
Cancer risk in x-ray technologists
|
ZIA CP010133-04180
|
$1,340,943
|
$26,819
|
Linet
|
DCEG (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
$65,681
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-26
|
$1,278,666
|
$25,573
|
Bury, Martin
|
SPECTRUM HEALTH HOSPITALS
|
|
Branch Clinical Research Core
|
ZID BC 010963
|
$1,239,800
|
$123,980
|
Gress, Ronald
|
CCR (NCI)
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-05
|
$1,195,618
|
$119,562
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,107,977
|
$553,988
|
Samelson, Lawrence
|
CCR (NCI)
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$539,916
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Immunohistochemistry Core Laboratory
|
ZIC BC 011087
|
$966,093
|
$96,609
|
Raffeld, Mark
|
CCR (NCI)
|
|
Marshfield Community Clinical Oncology Program
|
5U10CA035412-26
|
$926,378
|
$18,528
|
Weiss, Matthias
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Receptor-directed Therapy
|
ZIA BC 010603
|
$924,184
|
$277,255
|
Janik, John
|
CCR (NCI)
|
|
Iowa Oncology Research Association
|
5U10CA035101-24
|
$865,544
|
$17,311
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
|
ZIC SC 010353
|
$854,426
|
$42,721
|
Wayne, Alan
|
CCR (NCI)
|
|
EORTC DATA CENTER
|
5U10CA011488-39
|
$809,323
|
$24,280
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
New Mexico Minority-Based Community Clinical Oncology Program
|
5U10CA086780-10
|
$789,847
|
$15,797
|
VERSCHRAEGEN, CLAIRE
|
UNIVERSITY OF NEW MEXICO
|
|
DNA Repair
|
ZIA BC 010283
|
$784,092
|
$133,296
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Nevada Cancer Research Foundation-Community Clinical Oncology Program
|
5U10CA035421-26
|
$762,058
|
$15,241
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-07S3
|
$749,797
|
$104,972
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$14,992
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-12
|
$747,189
|
$127,022
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-26
|
$747,046
|
$14,941
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-09
|
$725,501
|
$725,501
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
LSUHSC Minority-Based Community Clinical Oncology Program
|
2U10CA063845-11
|
$710,000
|
$14,200
|
VEITH, ROBERT
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
HAWAII MINORITY-BASED CCOP
|
5U10CA063844-16
|
$699,073
|
$13,981
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-08
|
$688,991
|
$13,780
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
Regulation of RANTES expression in T lymphocytes
|
ZIA BC 011025
|
$666,916
|
$133,383
|
Krensky, Alan
|
CCR (NCI)
|
|
Function of granulysin
|
ZIA BC 011026
|
$666,916
|
$100,037
|
Krensky, Alan
|
CCR (NCI)
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$642,853
|
$64,285
|
Levens, David
|
CCR (NCI)
|
|
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
|
ZIC BC 010630
|
$616,122
|
$61,612
|
Janik, John
|
CCR (NCI)
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
$12,200
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
Total relevant funding to Hodgkins disease for this search: $18,224,261
|